Last Price
3.34
Today's Change
+0.04 (1.21%)
Day's Change
3.29 - 3.34
Trading Volume
190,116
Exchange: Australian Securities Exchange Australian Securities Exchange
Currency: AUD AUD
Sector: Healthcare - Healthcare Healthcare - Healthcare
CEO: Mr. Michael C. Kavanagh BSc, M.B.A. Mr. Michael C. Kavanagh BSc, M.B.A.
Full Time Employees: 466 466
IPO Date: 2007-05-17 2007-05-17
Nanosonics Limited, together with its subsidiaries, operates as an infection prevention company in Australia and internationally. The company engages in the manufacturing and distribution of the trophon ultrasound probe disinfector, and its associated consumables and accessories; and research, development, and commercialization of infection control and decontamination products and related technologies. It provides trophon2, an ultrasound probe high level disinfection device; trophon EPR, a low temperature high level disinfection solution for intra-cavity ultrasound probes; and Nanosonics AuditPro, an infection control workflow compliance management solution. Nanosonics Limited was incorporated in 2000 and is headquartered in Macquarie Park, Australia.